Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer - ScienceDirect
Frontiers | Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer | Oncotarget
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy: Trends in Cancer
Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer | Scientific Reports
PD-L1 is a negative prognostic marker for patients with mesothelioma.... | Download Scientific Diagram
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - ScienceDirect
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma | Virchows Archiv
Präzisionsmedizin - PD-L1 | Ihr Fachportal für Onkologie und Hämatologie | BMS-Onkologie
PD-L1 on dendritic cells controls the antitumor response
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
A snapshot of the PD-1/PD-L1 pathway
IJMS | Free Full-Text | Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice
PD-L1 expression on tumor cells (TC) and tumor infiltrating immune... | Download Scientific Diagram
Immun-Checkpoint Marker - Antikörper für die Immunhistochemie | BIOZOL
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer - eBioMedicine
Recent Advancement of PD-L1 Detection Technologies and Clinical Applications in the Era of Precision Cancer Therapy
Tumor-associated PD-L1-positive immune cells stain positive for... | Download Scientific Diagram
Repurposing Ponatinib as a PD-L1 Inhibitor Revealed by Drug Repurposing Screening and Validation by In Vitro and In Vivo Experiments | ACS Pharmacology & Translational Science
JCI - Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer - eBioMedicine
